Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease

Journal of Allergy and Clinical Immunology

Volumn 119, Issue 1, 2007, Pages 157-164

  Lee, Jennifer Y ^a   Simon, Ronald A ^b   Stevenson, Donald D ^a  

^a SCRIPPS CLINIC   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

5 lipoxygenase inhibitor; Aspirin; aspirin desensitization; aspirin exacerbated respiratory disease; leukotriene receptor antagonist; nonsteroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; METHYLPREDNISOLONE; MONTELUKAST; PREDNISONE; ZAFIRLUKAST;

ANGIONEUROTIC EDEMA; ANOSMIA; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESENSITIZATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSPEPSIA; ECCHYMOSIS; HOSPITALIZATION; HUMAN; INFECTION; LONG TERM CARE; MAJOR CLINICAL STUDY; OPTIMAL DRUG DOSE; PARANASAL SINUS; PARANASAL SINUS DISEASE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; TINNITUS; URTICARIA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DESENSITIZATION, IMMUNOLOGIC; HUMANS; RESPIRATORY TRACT DISEASES; TREATMENT OUTCOME;

EID: 33845928999     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.09.011     Document Type: Article

References (15)

1. Szczeklik A.S.D. Aspirin-induced asthma: advances in pathogenesis, diagnosis and management. J Allergy Clin Immunol 111 (2003) 913-921
2. Dahlen S., Malstrom K., Nizankowska E., Dahlen B., Kuna P., Kowalski M., et al. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist. A randomised, double blind, placebo controlled trial. Am J Respir Crit Care Med 165 (2002) 9-14
3. Dahlen B., Nizankowska E., Szczeklik A., Zetterstrom O., Bochenek G., Kumlin M., et al. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med 157 (1998) 1187-1194
4. Berges-Gimeno M., Simon R.A., and Stevenson D.D. The natural history and clinical characteristics of aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol 89 (2002) 474-478
5. Borish L. Sinusitis and asthma: entering the realm of evidence-based medicine. J Allergy Clin Immunol 109 (2002) 606-607
6. Stevenson D.D. Aspirin desensitization in patients with AERD. Clin Rev Allergy Immunol 24 (2003) 159-167
7. Chiu J.T. Improvement in aspirin-sensitive asthmatic subjects after rapid aspirin desensitization and aspirin maintenance (ADAM) treatment. J Allergy Clin Immunol 71 (1983) 560-567
8. Stevenson D.D., Pleskow W.W., Simon R.A., Mathison D.A., Lumry W.R., Schatz M., et al. Aspirin-sensitive rhinosinusitis asthma: a double-blind cross-over study of treatment with aspirin. J Allergy Clin Immunol 73 (1984) 500-507
9. Sweet J.A., Stevenson D.D., Simon R.A., and Mathison D.A. Long term effects of aspirin desensitization treatment for aspirin sensitive rhinosinusitis asthma. J Allergy Clin Immunol 86 (1990) 59-65
10. Stevenson D.D., Hankammer M.A., Mathison D.A., Christensen S.C., and Simon R.A. Long term ASA desensitization-treatment of aspirin sensitive asthmatic patients: clinical outcome studies. J Allergy Clin Immunol 98 (1996) 751-758
11. Berges-Gimeno M., Simon R.A., and Stevenson D.D. Treatment with aspirin desensitization in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol 111 (2003) 180-186
12. Stevenson D.D. Oral challenge: aspirin, NSAID, tartrazine, and sulfites. N Engl Res Allergy Proc 5 (1984) 111-116
13. Peto R., Gray R., Collins R., Wheatly K., Hennekens C., Jamrozik K., et al. Randomized trial of prophylactic daily aspirin in British male doctors. BMJ 296 (1988) 313-316
14. Wolfe M.M., Lichtenstein D.R., and Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 340 (1999) 661-669
15. Lewis H.D., Davis J.W., Archibald D.G., Steinke W.E., Smitherman T.C., Doherty J.E., et al. Protective effect of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration cooperative study. N Engl J Med 309 (1983) 396-403